Antibodies against Borrelia burgdorferi sensu lato among Adults, Germany, 2008–2011

To assess Borrelia burgdorferi sensu lato (the cause of Lyme borreliosis) seropositivity in Germany, we tested serum samples from health survey (2008–2011) participants. Seroprevalence was 5.8% among women and 13.0% among men; infection risk was highest among persons >60 years of age. Public health interventions, including education about risk factors and preventive measures, are needed.

[1]  H. Wilking,et al.  Trends in surveillance data of human Lyme borreliosis from six federal states in eastern Germany, 2009-2012. , 2014, Ticks and tick-borne diseases.

[2]  R. Nadelman,et al.  Differentiation of reinfection from relapse in recurrent Lyme disease. , 2012, The New England journal of medicine.

[3]  Gert B. M. Mensink,et al.  German health interview and examination survey for adults (DEGS) - design, objectives and implementation of the first data collection wave , 2012, BMC Public Health.

[4]  G. Poggensee,et al.  Seropositivity of Lyme Borreliosis and Associated Risk Factors: A Population-Based Study in Children and Adolescents in Germany (KiGGS) , 2012, PloS one.

[5]  M. Cartter,et al.  Effect of Surveillance Method on Reported Characteristics of Lyme Disease, Connecticut, 1996–2007 , 2012, Emerging infectious diseases.

[6]  M. Neteler,et al.  Lyme borreliosis in Europe. , 2011, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[7]  M. Hommes,et al.  Large differences between test strategies for the detection of anti-Borrelia antibodies are revealed by comparing eight ELISAs and five immunoblots , 2011, European Journal of Clinical Microbiology & Infectious Diseases.

[8]  F. Strle,et al.  Epidemiological aspects and molecular characterization of Borrelia burgdorferi s.l. from southern Germany with special respect to the new species Borrelia spielmanii sp. nov. , 2008, International journal of medical microbiology : IJMM.

[9]  M. Haude,et al.  Lyme-Borreliose in einem europäischen Endemiegebiet: Antikörperprävalenz und klinisches Spektrum , 2008 .

[10]  A. Marangoni,et al.  Borrelia burgdorferi VlsE antigen for the serological diagnosis of Lyme borreliosis , 2008, European Journal of Clinical Microbiology & Infectious Diseases.

[11]  M. G. Ciufolini,et al.  Prevalence and incidence of antibodies to Borrelia burgdorferi and to tick-borne encephalitis virus in agricultural and forestry workers from Tuscany, Italy , 2005, European Journal of Clinical Microbiology and Infectious Diseases.

[12]  D. Dennis,et al.  Surveillance for Lyme disease--United States, 1992-1998. , 2000, MMWR. CDC surveillance summaries : Morbidity and mortality weekly report. CDC surveillance summaries.

[13]  H. Karch,et al.  Incidence of Lyme Borreliosis in the Würzburg Region of Germany , 1999, European Journal of Clinical Microbiology and Infectious Diseases.

[14]  A. Lindberg,et al.  An epidemiologic study of Lyme disease in southern Sweden. , 1995, The New England journal of medicine.

[15]  C. Ciufecu,et al.  Seroprevalence of Borrelia burgdorferi in Romania , 2004, European Journal of Epidemiology.

[16]  P. Wahlberg,et al.  IgG seroprevalence of Lyme borreliosis in the population of the Aland Islands in Finland. , 1998, Scandinavian journal of infectious diseases.

[17]  L. Zöller,et al.  [Lyme borreliosis in an endemic region in Europe. Prevalence of antibodies and clinical spectrum]. , 1992, Deutsche medizinische Wochenschrift.

[18]  E P Dekonenko,et al.  [The clinical manifestations and diagnosis of Lyme borreliosis]. , 1989, Terapevticheskii arkhiv.